{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T23:14:00Z","timestamp":1778886840923,"version":"3.51.4"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetes Ther"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1007\/s13300-017-0342-8","type":"journal-article","created":{"date-parts":[[2017,11,24]],"date-time":"2017-11-24T04:16:24Z","timestamp":1511496984000},"page":"427-430","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["SGLT1 and SGLT1 Inhibitors: A Role to Be Assessed in the Current Clinical Practice"],"prefix":"10.1007","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8883-4776","authenticated-orcid":false,"given":"Leonardo","family":"Spatola","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Finazzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio","family":"Angelini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Dauriz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"Badalamenti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,11,24]]},"reference":[{"key":"342_CR1","doi-asserted-by":"crossref","first-page":"C14","DOI":"10.1152\/ajpcell.00388.2010","volume":"300","author":"CS Hummel","year":"2011","unstructured":"Hummel CS, Lu C, Loo DD, et al. Glucose transport by human renal Na+\/d-glucose cotransporters SGLT1 and SGLT2. Am J Physiol Cell Physiol. 2011;300:C14\u201321.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"2","key":"342_CR2","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S2213-8587(13)70050-0","volume":"1","author":"AA Tahrani","year":"2013","unstructured":"Tahrani AA, Barnett AH, Bailey CJ. SGLT inhibitors in management of diabetes. Lancet Diabetes Endocrinol. 2013;1(2):140\u201351.","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"9","key":"342_CR3","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1111\/dom.12970","volume":"19","author":"A Solini","year":"2017","unstructured":"Solini A, Rossi C, Mazzanti CM, et al. Sodium-glucose co-transporter (SGLT)2 and SGLT1 renal expression in patients with type 2 diabetes. Diabetes Obes Metab. 2017;19(9):1289\u201394.","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"342_CR4","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1016\/j.diabres.2008.11.003","volume":"83","author":"NM Tabatabai","year":"2009","unstructured":"Tabatabai NM, Sharma M, Blumenthal SS, et al. Enhanced expressions of sodium-glucose cotransporters in the kidneys of diabetic Zucker rats. Diabetes Res Clin Pract. 2009;83(1):e27\u201330.","journal-title":"Diabetes Res Clin Pract"},{"issue":"9","key":"342_CR5","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1007\/s00424-014-1619-7","volume":"467","author":"I Vrhovac","year":"2015","unstructured":"Vrhovac I, Balen Eror D, Klessen D, et al. Localizations of Na(+)-d-glucose cotransporters SGLT1 and SGLT2 in human kidney and of SGLT1 in human small intestine, liver, lung, and heart. Pflugers Arch. 2015;467(9):1881\u201398.","journal-title":"Pflugers Arch"},{"issue":"12","key":"342_CR6","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.2337\/diabetes.54.12.3427","volume":"54","author":"H Rahmoune","year":"2005","unstructured":"Rahmoune H, Thompson PW, Ward JM, et al. Glucose transporters in human renal proximal tubular cells isolated from the urine of patients with non-insulin-dependent diabetes. Diabetes. 2005;54(12):3427\u201334.","journal-title":"Diabetes"},{"issue":"9","key":"342_CR7","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1111\/dom.13003","volume":"19","author":"L Norton","year":"2017","unstructured":"Norton L, Shannon CE, Fourcaudot M, et al. Sodium-glucose co-transporter (SGLT) and glucose transporter (GLUT) expression in the kidney of type 2 diabetic subjects. Diabetes Obes Metab. 2017;19(9):1322\u20136.","journal-title":"Diabetes Obes Metab"},{"key":"342_CR8","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.2337\/db12-0052","volume":"61","author":"JJ Liu","year":"2012","unstructured":"Liu JJ, Lee T, DeFronzo RA. Why do SGLT2 inhibitors inhibit only 30\u201350% of renal glucose reabsorption in humans? Diabetes. 2012;61:2199\u2013204.","journal-title":"Diabetes"},{"key":"342_CR9","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/dom.12090","volume":"15","author":"JF Yale","year":"2013","unstructured":"Yale JF, Bakris G, Cariou B, et al. Efficacy and safety of canagliflozin in subjects with type 2 diabetes and chronic kidney disease. Diabetes Obes Metab. 2013;15:463\u201373.","journal-title":"Diabetes Obes Metab"},{"key":"342_CR10","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2337\/db11-1029","volume":"61","author":"V Gorboulev","year":"2012","unstructured":"Gorboulev V, Schurmann A, Vallon V, et al. Na(+)-d-glucose cotransporter SGLT1 is pivotal for intestinal glucose absorption and glucose-dependent incretin secretion. Diabetes. 2012;61:187\u201396.","journal-title":"Diabetes"},{"key":"342_CR11","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1210\/en.2007-1088","volume":"149","author":"HS Freitas","year":"2008","unstructured":"Freitas HS, Anhe GF, Melo KF, et al. Na(+)-glucose transporter-2 messenger ribonucleic acid expression in kidney of diabetic rats correlates with glycemic levels: involvement of hepatocyte nuclear factor-1alpha expression and activity. Endocrinology. 2008;149:717\u201324.","journal-title":"Endocrinology"},{"key":"342_CR12","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/ng0296-216","volume":"12","author":"MG Martin","year":"1996","unstructured":"Martin MG, Turk E, Lostao MP, et al. Defects in Na+\/glucose cotransporter (SGLT1) trafficking and function cause glucose-galactose malabsorption. Nat Genet. 1996;12:216\u201320.","journal-title":"Nat Genet"},{"key":"342_CR13","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/clpt.2012.58","volume":"92","author":"B Zambrowicz","year":"2012","unstructured":"Zambrowicz B, Freiman J, Brown PM, et al. LX4211, a dual SGLT1\/SGLT2 inhibitor, improved glycemic control in patients with type 2 diabetes in a randomized, placebo-controlled trial. Clin Pharmacol Ther. 2012;92:158\u201369.","journal-title":"Clin Pharmacol Ther"},{"key":"342_CR14","doi-asserted-by":"crossref","first-page":"G946","DOI":"10.1152\/ajpgi.00286.2014","volume":"308","author":"RL Dobbins","year":"2015","unstructured":"Dobbins RL, Greenway FL, Chen L, et al. Selective sodium-dependent glucose transporter 1 inhibitors block glucose absorption and impair glucose-dependent insulinotropic peptide release. Am J Physiol Gastrointest Liver Physiol. 2015;308:G946\u201354.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"2","key":"342_CR15","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1021\/acs.jmedchem.6b01541","volume":"60","author":"NC Goodwin","year":"2017","unstructured":"Goodwin NC, Ding ZM, Harrison BA, et al. Discovery of LX2761, a Sodium-dependent glucose cotransporter 1 (SGLT1) inhibitor restricted to the intestinal lumen, for the treatment of diabetes. J Med Chem. 2017;60(2):710\u201321.","journal-title":"J Med Chem"}],"container-title":["Diabetes Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-017-0342-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,2,6]],"date-time":"2018-02-06T02:35:07Z","timestamp":1517884507000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13300-017-0342-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,24]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["342"],"URL":"https:\/\/doi.org\/10.1007\/s13300-017-0342-8","relation":{},"ISSN":["1869-6953","1869-6961"],"issn-type":[{"value":"1869-6953","type":"print"},{"value":"1869-6961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,24]]}}}